3D Printed Drugs Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024. Increase in demand for fast soluble drugs which can disperse easily in the mouth is the key factor that gives growth to the global 3D printed drugs market.
Global 3D Printed Drugs market is valued at USD 272.17million in 2018 and expected to reach USD 437.04 million by 2025 with a CAGR of 7.0 % over the forecast period.
Scope of Global 3D Printed Drugs Market Reports –
3D printed drugs are medications, which are designed by 3D printing technique to modify for individuals in a safe and effective way. 3D printed drugs are developed by using powder-liquid three dimensional printing technologies. This technique uses an aqueous fluid which is able to bind different or similar layer of powders and produces multiple types of products. Additionally, 3D printed drugs are able to liquefy unsolvable compounds such as silver chloride very easily. The main objective and one of the major benefits of 3D printed drugs is how they will be able to be constructed with an individual’s specific requirements in mind, and even created in line with certain preferences. Factors like the size, dose, appearance and rate of delivery of a drug can be controlled. So, during the study of 3D printed drugs market, we have considered 3D printed drugs and therapy to analyze the market.
Get Sample Copy of This Premium Report @ https://industrystatsreport.com/Request/Sample?ResearchPostId=746&RequestType=Sample
Global 3D Printed Drugs Market report is segmented on the basis of drug, end users, applications and by regional & country level. Based upon drug, global 3D printed drugs market is segmented into sprit am and others. Based upon applications, global 3D printed drugs market is segmented as neurology, orthopedic, hearing and audibility aid, dental, medical implants and others. Based upon end users global 3D printed drugs market is segmented into hospitals, clinics and research laboratories.
The regions covered in this 3D printed drugs market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of 3D Printed Drugs is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Key Players for Global 3D Printed Drugs Market Reports–
Some major key players for global 3D Printed Drugs market are 3D Printer Drug Machine, Aprecia Pharmaceuticals, Hewlett Packard Caribe, BV, LLC, GlaxoSmithKline Plc., FabRx Ltd., Cycle Pharmaceuticals and others.
In 2017, Aprecia Pharmaceuticals and Cycle Pharmaceuticals have signed a partnership agreement to develop and commercialized orphan drugs using three-dimensionally printed (“3DP”) technology. The planned products will deliver quality-oflife improvements versus existing, approved orphan’s drugs, and will achieve this by utilizing Aprecia’s proprietary 3DP ZipDose Technology platform. ZipDose is the only three dimensional printing technology used in a pharmaceutical drug product approved by the U.S. Food and Drug Administration.
Global 3D Printed Drugs Market Dynamics –
Continuous technological development in 3D printing techniques, increase in awareness about the 3D printing technology in developing countries and rise in incidence of epilepsy cases drive the growth of the market. According to WHO, Epilepsy accounts for a significant proportion of the world‘s disease burden, affecting more than 50 million people worldwide. The expected proportion of the general population with active epilepsy at a given time is between 4 and 10 per 1000 people. But some studies in low-and middle-income countries suggest that the proportion is higher, between 7 and 15 per 1000 people. Moreover with the point of view on diagnosed rate globally, an estimated 2.4 million people are diagnosed with epilepsy each year. Also, lack of government regulations related to these drugs and adverse effect of 3D printed drugs are expected to limit the market growth. Nonetheless, big pharmaceuticals companies are heavily investing into the 3D printing drug technology and are expected to enter into this market in near future.
Request for Methodology @ https://industrystatsreport.com/Request/Sample?ResearchPostId=746&RequestType=Methodology
The global 3D printed drugs market is segmented into North America, Europe, Asia-Pacific and Rest of the World (ROW). North America dominates 3D printed drugs market due to their pharmaceutical companies presents worldwide along with them having a strong domestic healthcare infrastructure. The pharmaceutical sector is highly dependent on R&D spending which also explains their continued dominance. Asia Pacific countries like China and India are expected to record the highest growth in the 3D printed drugs market due to massive investments in both R&D & the pharmaceutical industry.
Key Benefits for Global 3D Printed Drugs Market Reports –
Global 3D Printed Drugs Market report covers in-depth historical and forecast analysis.
Global 3D Printed Drugs Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
Global 3D Printed Drugs Market report helps to identify opportunities in marketplace.
Global 3D Printed Drugs Market report covers extensive analysis of emerging trends and competitive landscape.
Get Full information of This Report @ https://industrystatsreport.com/Lifesciences-and-Healthcare/3D-Printed-Drugs-Market-Size/Summary
Global 3D Printed Drugs Market Segmentation
Hearing and Audibility Aid
Dental, Medical Implants
By Regional & Country Analysis
Middle East and Africa
Rest of Middle East and Africa
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global 3D Printed Drugs Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global 3D Printed Drugs Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. 3D Printed Drugs Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis
2.9.1. Market Attractiveness Analysis by Segmentation
2.9.2. Market Attractiveness Analysis by Region
3. Chapter – Global 3D Printed Drugs Market Overview: Quantitative Analysis
4. Chapter – Global 3D Printed Drugs Market Analysis: By Drugs
5. Chapter – Global 3D Printed Drugs Market Analysis: By Application
6. Chapter – Global 3D Printed Drugs Market Analysis: By End-User
7. Chapter – Global 3D Printed Drugs Market Analysis: By Manufacturer
9. Chapter – Company Profiles
9.1. 3D Printer Drug Machine
9.2. Fluke Calibration
9.2.2. Product portfolio
9.2.3. 3D Printed Drugs Market Revenue (USD Million) and Market Share (%), 2014 – 2018
9.2.4. 3D Printed Drugs Sales Market Share (%), 2014 – 2018
9.2.5. Business strategy
9.2.6. Recent developments
9.3. 3D Printer Drug Machine
9.4. Aprecia Pharmaceuticals
9.5. Hewlett Packard Caribe
9.8. GlaxoSmithKline Plc.
9.9. FabRx Ltd.
9.10. Cycle Pharmaceuticals
About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org